Equities

Xiangyu Medical Co Ltd

688626:SHH

Xiangyu Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)32.36
  • Today's Change0.23 / 0.72%
  • Shares traded1.65m
  • 1 Year change-37.78%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Xiangyu Medical Co Ltd is a China-based company mainly engaged in rehabilitation medical equipment industry. The Company is mainly engaged in the independent research and development, production and marketing of intelligent rehabilitation equipment in the rehabilitation fields such as pain, neurology, orthopedics, traditional Chinese medicine, postpartum field, postoperative field, cardiopulmonary field, and medical-care integration. The Company's main products are divided into three categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy. The Company mainly conducts business within the domestic market.

  • Revenue in CNY (TTM)709.56m
  • Net income in CNY121.39m
  • Incorporated2002
  • Employees1.82k
  • Location
    Xiangyu Medical Co LtdMiddle Section of Diku AvenueNeihuang CountyANYANG 456000ChinaCHN
  • Phone+86 3 727776088
  • Fax+86 3 727776066
  • Websitehttps://www.xyyl.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Jiangsu Bioperfectus Technologies Co Ltd394.84m-170.68m4.59bn684.00--1.40--11.62-2.91-2.916.7458.000.0970.97472.52577,244.10-4.1925.41-4.7431.2665.7063.37-43.2332.864.96--0.090330.54-92.7211.81-120.45--2.43--
TINAVI Medical Technologies Co Ltd168.49m-160.48m4.60bn339.00--3.90--27.29-0.3585-0.35850.37562.620.10751.484.73475,961.90-10.24-7.86-11.04-9.0768.6673.58-95.24-50.092.21--0.1532--34.4810.63-41.42--51.87--
Assure Tech Hangzhou Co Ltd590.49m90.50m4.80bn791.0053.040.9316--8.130.7120.7124.6540.530.10111.902.85746,504.601.5531.831.7138.9736.8765.8215.3047.868.66--0.012516.05-91.8425.18-95.3533.5178.77--
Beijing Chunlizhengda Mdicl Instr Co Ltd924.65m158.35m4.82bn1.23k34.751.94--5.210.40780.40782.417.290.26980.53812.15751,138.904.6212.535.4915.4371.0872.7617.1226.893.80--0.000321.630.575919.40-9.7221.33-8.60--
Zhejiang Gongdong Medical Techno Co Ltd1.10bn162.27m4.90bn1.67k30.172.94--4.461.031.036.9510.570.56846.554.33656,174.208.4016.359.7119.2632.4841.1914.7721.623.00--0.052138.99-33.6115.11-66.535.1427.71--
Hangzhou Ags Medtech Co Ltd590.12m271.52m4.95bn592.0018.212.15--8.393.363.367.3028.530.25453.2713.92996,828.3011.71--12.26--71.52--46.01--19.56--0.003--37.09--49.87------
Xiangyu Medical Co Ltd709.56m121.39m5.18bn1.82k42.022.56--7.300.770.774.5212.660.25961.0114.80390,085.104.4411.185.6213.1266.0366.7817.1232.691.43--0.141727.3352.4615.7281.0323.11132.76--
Hangzhou Alltest Biotech Co Ltd812.78m276.54m5.25bn1.09k18.941.32--6.463.503.5010.2650.020.1982.216.97743,626.506.7423.357.2226.8353.6958.3434.0339.0710.46--0.002229.79-77.7332.59-84.7526.1972.77--
Shanghai Sanyou Medical Co Ltd434.20m37.87m5.26bn466.00147.822.75--12.110.14320.14321.717.690.19510.61915.15931,756.402.099.422.4110.8570.7287.1510.7329.783.27--0.013516.21-29.0815.67-49.918.99-15.60--
Innovita Biological Technology Co Ltd720.40m332.01m5.82bn404.0017.462.85--8.072.442.445.3014.980.35843.189.161,783,177.0016.52--17.42--80.70--46.09--16.01--0.001--7.03--15.44------
Data as of Nov 15 2024. Currency figures normalised to Xiangyu Medical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

0.15%Per cent of shares held by top holders
HolderShares% Held
Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024544.32k0.03%
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2024434.26k0.03%
The Vanguard Group, Inc.as of 02 Oct 2024335.29k0.02%
Truvalue Asset Management Co. Ltd.as of 30 Jun 2024239.86k0.02%
Lion Fund Management Co., Ltd.as of 30 Jun 2024233.28k0.02%
Acadian Asset Management LLCas of 30 Sep 2024187.55k0.01%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 2024169.20k0.01%
HSBC Jintrust Fund Management Co. Ltd.as of 30 Jun 202470.04k0.00%
China Asset Management Co., Ltd.as of 30 Jun 202468.84k0.00%
JX Asset Management Co.,Ltdas of 30 Jun 202448.37k0.00%
More ▼
Data from 30 Jun 2024 - 27 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.